|
Volumn 16, Issue 5, 2008, Pages 1222-1226
|
[Clinical significance of Helicobacter pylori in pathogenesis of idiopathic thrombocytopenic purpura].
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
GLUCOCORTICOID;
ADULT;
ARTICLE;
CASE CONTROL STUDY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HUMAN;
IDIOPATHIC THROMBOCYTOPENIC PURPURA;
MALE;
MICROBIOLOGY;
MULTIMODALITY CANCER THERAPY;
RANDOMIZED CONTROLLED TRIAL;
THROMBOCYTE COUNT;
ADULT;
ANTI-BACTERIAL AGENTS;
CASE-CONTROL STUDIES;
COMBINED MODALITY THERAPY;
FEMALE;
GLUCOCORTICOIDS;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
MALE;
PLATELET COUNT;
PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;
|
EID: 79960655842
PISSN: 10092137
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|